Australia markets open in 6 hours 34 minutes

Benitec Biopharma Inc. (BNTC)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.3634+0.0200 (+5.82%)
As of 01:06PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 8.27M
Enterprise value 5.02M
Trailing P/E 51.55
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)35.88
Price/book (mrq)2.87
Enterprise value/revenue 68.78
Enterprise value/EBITDA -0.28

Trading information

Stock price history

Beta (5Y monthly) 1.25
52-week change 3-90.39%
S&P500 52-week change 3-13.66%
52-week high 33.9000
52-week low 30.3010
50-day moving average 30.6903
200-day moving average 31.6117

Share statistics

Avg vol (3-month) 3304.08k
Avg vol (10-day) 3187.18k
Shares outstanding 525.81M
Implied shares outstanding 6N/A
Float 87.85M
% held by insiders 113.98%
% held by institutions 121.72%
Shares short (30 Aug 2022) 4354.88k
Short ratio (30 Aug 2022) 43.92
Short % of float (30 Aug 2022) 44.96%
Short % of shares outstanding (30 Aug 2022) 44.34%
Shares short (prior month 28 July 2022) 461.72k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 317 Nov 2019
Ex-dividend date 4N/A
Last split factor 22:3
Last split date 314 Apr 2020

Financial highlights

Fiscal year

Fiscal year ends 29 June 2022
Most-recent quarter (mrq)29 June 2022


Profit margin 0.00%
Operating margin (ttm)-24,457.53%

Management effectiveness

Return on assets (ttm)-81.59%
Return on equity (ttm)-159.08%

Income statement

Revenue (ttm)73k
Revenue per share (ttm)0.01
Quarterly revenue growth (yoy)-100.00%
Gross profit (ttm)64k
EBITDA -17.69M
Net income avi to common (ttm)-18.21M
Diluted EPS (ttm)-2.1720
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)4.06M
Total cash per share (mrq)0.5
Total debt (mrq)811k
Total debt/equity (mrq)28.14
Current ratio (mrq)1.90
Book value per share (mrq)0.35

Cash flow statement

Operating cash flow (ttm)-15.9M
Levered free cash flow (ttm)-8.72M